Phase 3 Study to Evaluate the Efficacy and Safety of Co-administrated AD-2021 and AD-2022

Clinical trial NCT06448962 · COMPLETED

Trial details

NCT number: NCT06448962
Sponsor: Addpharma Inc.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Hypertension, Essential Primary Hypercholesterolemia

Start date: 2020-10-22
Primary completion: 2021-11-22
Enrollment: 109

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.